Lin Chen
About Lin Chen
Lin Chen is a Principal Scientist at Bristol Myers Squibb with over a decade of experience in the pharmaceutical industry, specializing in medicinal and pharmaceutical chemistry.
Title at Bristol Myers Squibb
Lin Chen currently serves as a Principal Scientist at Bristol Myers Squibb in Summit, NJ. Chen has been with the company since April 2019.
Previous Experience at XenoBiotic Laboratories Inc./WuXi AppTec
Lin Chen worked at XenoBiotic Laboratories Inc./WuXi AppTec from 2013 to 2019 as a Research Scientist II / Study Director. During this period, Chen contributed to various research projects that aided in the company's growth within the field of pharmaceutical research. The role was based in Plainsboro/Cranbury, NJ.
Educational Background and Internship at Janssen
Lin Chen attended Rutgers University from 2007 to 2013, studying Medicinal and Pharmaceutical Chemistry. During this time, Chen gained practical experience through an internship at Janssen, Pharmaceutical Companies of Johnson and Johnson, working there for three months in 2012.
Experience at Rutgers University
Chen served as a Graduate/Teaching Assistant at Rutgers University from 2007 to 2013. This role involved both teaching and research responsibilities, providing a strong foundation in academic and scientific principles.
Research Contributions and Areas of Expertise
Lin Chen has extensive experience in the pharmaceutical industry, working on the development of innovative treatments for immune-mediated diseases, Direct Acting Antiviral (DAA) therapy for Hepatitis C, novel oral anticoagulants (NOACs) for atrial fibrillation, and treatments for rheumatoid arthritis and other rheumatic diseases. Chen has also contributed to advancements in oncology, particularly in Immuno-Oncology agents, and has been involved in the research and development of treatments for HIV/AIDS and various cancers, including lung cancer, melanoma, and kidney cancer.